Market Overview:
Prochlorperazine maleate is an antipsychotic medication used primarily to control severe nausea and vomiting. It is commonly used to treat nausea and vomiting caused by conditions like motion sickness, vertigo, epilepsy, migraines, diabetes, surgery, cancer chemotherapy and labor. It works by blocking dopamine receptors in the brain. The drug is available in oral tablet, injection and suppository forms.

Market Dynamics:
The prochlorperazine maleate market is driven by increasing prevalence of nausea and vomiting related conditions globally. Nausea and vomiting is a common side effect associated with cancer chemotherapy. According to WHO, there were around 18.1 million new cases and 9.6 million cancer related deaths in 2018 globally. Additionally, the rise in cases of postoperative nausea and vomiting (PONV), especially due to growing number of surgeries is also expected to boost market growth during the forecast period. However, availability of alternative therapies for nausea and vomiting may hinder market growth. Additionally, side effects associated with prochlorperazine maleate like extrapyramidal symptoms including tremors and restlessness may also restrain the market growth.

Key Takeaways

The global Prochlorperazine Maleate Market Size is expected to witness high growth, exhibiting CAGR of 3.5% over the forecast period, due to increasing prevalence of cancer and gastrointestinal diseases.

Read More: https://www.feedsfloor.com/industrial/prochlorperazine-maleate-estimated-witness-high-growth-owing-increasing-preference-nausea